<?xml version="1.0" encoding="UTF-8"?>
<p>More than 15 potential vaccine candidates for COVID-19 are under development around the world, including inactivated, recombinant subunits, nucleic-acid-based, adenoviral vector, and recombinant influenza viral vector vaccines [
 <xref rid="B208-ijerph-17-05648" ref-type="bibr">208</xref>]. Moreover, taking into consideration the strong homologies existing among the various coronavirus strains, it was thought that vaccines acting on other coronaviruses, such the avian live IBV vaccine (strain H) directed towards the chicken CoV IBV, could be a valuable alternative therapeutic strategy [
 <xref rid="B209-ijerph-17-05648" ref-type="bibr">209</xref>].
</p>
